Development Level

Tbio 2 | 10,625
Tclin 2 | 602
Tchem 1 | 1,890

Disease

Alzheimer's disease 4 | 644
Obesity 4 | 616
psoriasis 4 | 6,685
Cancer 3 | 2,346
Hyperactive behavior 3 | 31
Infertility 3 | 163
Mammary Neoplasms, Experimental 3 | 150
Pain agnosia 3 | 99
Schizophrenia 3 | 501
lung cancer 3 | 4,466
ovarian cancer 3 | 8,484
Adenocarcinoma 2 | 115
Animal Mammary Neoplasms 2 | 136
Anxiety Disorders 2 | 37
Anxiety disorder 2 | 22
Atrophic vaginitis 2 | 14
Autistic Disorder 2 | 320
Bladder Neoplasm 2 | 109
Cocaine-Related Disorders 2 | 88
Coronary artery disease 2 | 240
Diarrhea 2 | 155
Dyspareunia 2 | 3
Endometrial Neoplasms 2 | 50
Endometriosis 2 | 535
Female hypogonadism syndrome 2 | 7
Female infertility 2 | 28
Hypertension 2 | 287
Male infertility 2 | 170
Mammary Neoplasms 2 | 410
Menopausal flushing 2 | 17
Metastatic Breast Cancer Progression Post-Antiestrogen Therapy 2 | 4
Osteoporosis 2 | 257
Parkinson's disease 2 | 364
Postmenopausal osteoporosis 2 | 19
Prevention of Breast Carcinoma 2 | 5
Prostatic Intraepithelial Neoplasias 2 | 11
Prostatic Neoplasms 2 | 471
Vascular disease 2 | 281
astrocytoma 2 | 1,493
chronic kidney disease 2 | 90
diabetes mellitus 2 | 1,663
osteosarcoma 2 | 7,933
pituitary cancer 2 | 1,972
ATHEROSCLEROSIS, SUSCEPTIBILITY TO 1 | 3
Acne vulgaris 1 | 16
Advanced Prostatic Carcinoma 1 | 5
Amnestic disorder 1 | 37
Asperger syndrome 1 | 35
Atrophic vulva 1 | 6
Bilirubin metabolic disorder 1 | 39
Bradycardia 1 | 24
Breast Cancer, Familial 1 | 12
Breast disease 1 | 8
Breast fibroadenoma 1 | 8
Bulimia nervosa 1 | 15
Carcinoma of female breast 1 | 20
Carcinosarcoma 1 | 6
Catalepsy 1 | 15
Complex regional pain syndrome 1 | 12
Dumping syndrome 1 | 9
Duodenal ulcer 1 | 20
ESTROGEN RESISTANCE 1 | 1
Eating disorder 1 | 24
Ectopic pregnancy 1 | 16
Edema 1 | 38
Endometrial cancer 1 | 25
Female Urogenital Diseases 1 | 18
Feminization 1 | 1
Fibroid Tumor 1 | 6
Glomerulonephritis 1 | 36
HDL CHOLESTEROL, AUGMENTED RESPONSE OF, TO HORMONE REPLACEMENT 1 | 1
Hypotension 1 | 53
Idiopathic scoliosis 1 | 29
Infiltrating duct carcinoma of breast 1 | 4
Ischemia 1 | 27
Leiomyoma 1 | 25
Leiomyosarcoma 1 | 19
Lobular neoplasia 1 | 15
Menorrhagia 1 | 8
Metabolic Bone Disorder 1 | 11
Metastatic Breast Carcinoma 1 | 21
Metastatic Prostate Carcinoma 1 | 18
Migraine Disorders 1 | 26
Muscle Rigidity 1 | 5
Myocardial Infarction 1 | 126
Neonatal jaundice 1 | 15
Neoplastic Cell Transformation 1 | 81
Oligohydramnios 1 | 18
Oligospermia 1 | 30
Oropouche fever 1 | 2
Ovarian dysfunction 1 | 19
Ovulation induction 1 | 4
Pain 1 | 70
Premenstrual dysphoric disorder 1 | 8
Prevention of Radiation-Induced Nausea and Vomiting 1 | 7
Primary ovarian failure 1 | 5
Psychoses, Substance-Induced 1 | 17
Retinoblastoma 1 | 14
Urethral atrophy 1 | 4
Uterine fibroid 1 | 29

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 3 | 11,971
Nuclear Receptor 2 | 48

Grant Application

7R01NS020311-20 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Estrogen receptor ESR1 Tclin Nuclear Receptor -3.97123 8119.2 2214
Neurotensin/neuromedin N NTS Tbio Non-IDG -3.53340 3485.1 161
Oxytocin-neurophysin 1 OXT Tbio Non-IDG -4.16090 14677.4 133
Estrogen receptor beta ESR2 Tclin Nuclear Receptor -3.53167 3575.4 950
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86